16/04/2014 03:28:52 Free Membership Login

   

Allergan

Visual Financials
Company Name: Allergan, Inc.
Ticker Symbol: AGN
WWW Address: http://www.allergan.com
CEO: David Pyott
No. of Employees: 10,800
Common Issue Type: CS
Business Description:Allergan, Inc., is a multi-specialty health care company develops and commercializes innovative pharmaceuticals, biologics and medical devices.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 127.8 Up 3.83 - - 124.31 127.96 123.97 5856258
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 37,977.4 297.2 0.69 4.23 0.00 26.4 0.0 132.04 - 81.33
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close127.80$
PE Ratio - LTM26.4
Market Capitalisation37,977.4mil
Latest Shares Outstanding297.2mil
Earnings pS (EPS)4.23$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee537,602$
Effective Tax Rate28.1%
Float297.1mil
Float as % of Shares Outstanding99.8%
Foreign Sales2,230mil
Domestic Sales3,478mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.00%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Assets Turnover0.0%
Return on Assets (ROA)0.0%
Return on Equity (ROE)0.0%
Return on Capital Invested (ROCI)0.0%
Current Ratio
Leverage Ratio (Assets/Equity)
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS0.00$
Cash pS5.54$
Book-Value pS20.48$
Tangible Book-Value pS0.00$
Cash Flow pS0.00$
Free Cash Flow pS0.00$
KEY FIGURES (LTM): Price info
Price/Book Ratio5.47
Price/Tangible Book Ratio0.00
Price/Cash Flow20.2
Price/Free Cash Flow22.2
P/E as % of Industry Group132.0%
P/E as % of Sector Segment102.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Dividend Declared Date04/30/2013
Dividend Ex-Date05/20/2013
Dividend Record Date05/22/2013
Dividend Pay Date06/12/2013
Dividend Amount50
Type of PaymentCash Payment
Dividend Rate0.20
Current Dividend Yield0.0
5-Y Average Dividend Yield0.3
Payout Ratio0.0
5-Y Average Payout Ratio9.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---5.163,792,03313,037,435
4 Weeks132.04115.94131.21-5.5-43,573,66275,046,915
13 Weeks132.04110.62114.428.372,900,047188,503,099
26 Weeks132.0488.3489.7138.2302,536,268319,569,788
52 Weeks132.0481.33113.129.6-72,467,828624,360,700
YTD132.04109.64-12.4122,808,911202,241,619
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
122.04122.39124.43108.21103.170.690.69
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue6.9496.97.29
Income0.000.00.00
Dividend0.000.00.00
Capital Spending-10.98NA48.20
R&D6.34NA10.78
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %4.94.97.1
Earnings %0.00.00.0
EPS %-94.6-94.618.9
EPS $-0.70-0.700.57
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio36.64
Current Ratio4.1
Quick Ratio (Acid Test)3.4
Liquidity Ratio (Cash)2.70
Receivables Turnover7.8
Average Collection Period46
Working Capital/Equity57.6
Working Capital pS11.20
Cash-Flow pS4.51
Free Cash-Flow pS3.43
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio7.77
Financial Leverage Ratio (Assets/Equity)1.6
Debt Ratio36.4
Total Debt/Equity (Gearing Ratio)0.27
LT Debt/Equity0.26
LT Debt/Capital Invested30.6
LT Debt/Total Liabilities45.3
Interest Cover25.1
Interest/Capital Invested0.79
 
VALUATION RATIOS
MULTIPLES
PQ Ratio12.58
Tobin's Q Ratio3.63
Current P/E Ratio - LTM26.40
Enterprise Value (EV)/EBITDA17.80
Enterprise Value (EV)/Free Cash Flow35.13
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM5.47
Price/Cash Flow Ratio20.2
Price/Free Cash Flow Ratio - LTM22.2
Price/Sales Ratio5.12
P/E Ratio (1 month ago) - LTM36.1
P/E Ratio (26 weeks ago) - LTM26.8
P/E Ratio (52 weeks ago) - LTM28.5
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group132.0
P/E as % of Sector Segment102.0
Current 12 Month Normalized P/E Ratio - LTM26.6
PER SHARE FIGURES
LT Debt pS5.04
Current Liabilities pS3.65
Tangible Book Value pS - LTM0.00
Book Value pS - LTM20.48
Capital Invested pS24.73
Cash pS - LTM5.54
Cash Flow pS - LTM0.00
Free Cash Flow pS - LTM0.00
Earnings pS (EPS)4.23
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin17.72
Free Cash Flow Margin 5YEAR AVG11.97
Net Profit Margin19.0
Net Profit Margin - 5YEAR AVRG.9.2
Equity Productivity0.99
Return on Equity (ROE)18.9
Return on Equity (ROE) - 5YEAR AVRG.9.3
Capital Invested Productivity0.79
Return on Capital Invested (ROCI)15.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.7.1
Assets Productivity0.70
Return on Assets (ROA)12.0
Return on Assets (ROA) - 5YEAR AVRG.5.7
Gross Profit Margin0.0
Gross Profit Margin - 5YEAR AVRG.87.6
EBITDA Margin - LTM0.0
EBIT Margin - LTM0.0
Pre-Tax Profit Margin26.4
Pre-Tax Profit Margin - 5YEAR AVRG.18.5
Effective Tax Rate28.1
Effective Tax Rate - 5YEAR AVRG.41.2
EFFICIENCY RATIOS
Cash Conversion Cycle193
Revenue per Employee537,602
Net Income per Employee102,083
Average Collection Period47
Receivables Turnover7.8
Day's Inventory Turnover Ratio146
Inventory Turnover2.5
Inventory/Sales4.9
Accounts Payble/Sales4.86
Assets/Revenue1.43
Net Working Capital Turnover1.73
Fixed Assets Turnover1.23
Total Assets Turnover0.7
Revenue per $ Cash2.15
Revenue per $ Plant6.81
Revenue per $ Common Equity0.99
Revenue per $ Capital Invested0.79
Selling, General & Adm/tive (SG&A) as % of Revenue39.1
SG&A Expense as % of Revenue - 5YEAR AVRG.43.6
Research & Devlopment (R&D) as % of Revenue17.0
R&D Expense as % of Revenue - 5YEAR AVRG.17.0

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse agn140416 03:28